Work

Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck

Year: 2016

Type: article

Study design: Clinical Trial

Source: Journal of Radiation Oncology

DOI: 10.1007/s13566-016-0279-y

Authors: Andrew M. McDonald, Roger Ove, James A. Bonner, Lisle M. Nabell, William R. Carroll, Nasser Said Al-Naief, Margaret Brandwein-Gensler, Sharon A. Spencer

Institutions: University of Alabama at Birmingham, University Hospitals Seidman Cancer Center, Case Western Reserve University, Oregon Health & Science University, University at Buffalo, State University of New York

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer

OpenAlex ID: W2531350797

FWCI:

Cites: 45

Cited by:

Related to: 10